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Background: Stroke leads to constant rehabilitation needs even at the chronic stage. However, although many
stroke patients receive physical or occupational therapy in primary health care, treatment prescriptions do not
generally specify therapeutic goals; in particular, participation is not established as an explicit therapeutic goal in
the ambulatory setting. The primary aim of this study is to evaluate the efficacy of a therapy regimen for chronic
stroke patients (modified ‘constraint-induced movement therapy (CIMT) at home’) with impaired hand or arm
function with regard to the prerequisites of participation in everyday activities: a sufficient arm and hand function.
‘CIMT at home’ will be compared with conventional physical and occupational therapy (‘therapy as usual’).
Methods/design: The study is a parallel cluster randomized controlled trial with therapy practices as clusters (n = 48).
After written consent from the patients (n = 144), the therapists will be randomly assigned to treat either the
intervention or the control group. Blinded external assessors will evaluate the patients using standardized outcome
measures before and after the intervention, and six months later. The two coprimary endpoint assessments of arm
and hand function as prerequisites for participation (defined as equal involvement in activities of daily living) are
the motor activity log (quality of arm and hand use) and the Wolf motor function test (arm and hand function).
These assessments are made four weeks post-treatment and relativized to baseline performance. Changes in
primary outcomes will be analyzed with mixed models, which consider the hierarchical structure of the data and
will be adjusted to the baseline measurements and sex. The primary analysis will be the comparison of the two
randomized groups, with respect to the adjusted averages for each of the two coprimary endpoints. To keep an overall
significance level of 5%, the two endpoints will be tested at the significance level of 5% each in hierarchical order.
Discussion: A modification of the CIMT, feasible in the patients’ homes (CIMT at home), appears to be a promising
therapeutic approach in the ambulatory care of chronic stroke patients. With proven efficacy and practicality, a
participation-oriented, stroke-specific treatment would be available in primary care.
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Stroke is the fourth leading cause of death in Germany
[1] and the most common cause of lifelong disability in
adults [2]. In the chronic phase, that is, six months or
more after the event, the aim is to maintain and, if pos-
sible, further improve the achieved results of rehabilita-
tion [3]. Apart from a variety of other problems, many
stroke patients suffer from impaired arm and hand func-
tion, which often affects their participation in everyday
activities. In the context of health, participation is de-
fined as involvement in a life situation and is related to
the execution of a task or action (activity) [4]. Thera-
peutic approaches aimed at enhancing participation in-
volve exercises that address the demands of daily life, in
an environment that at least resembles the patient’s indi-
vidual environment at home. Correspondingly, since
2001 in Germany, rehabilitation services are required by
law to prioritize participation as a treatment goal, rather
than merely providing social care [5]. Despite this, many
stroke patients who receive physical or occupational
therapy in the primary health care setting are provided
with therapy prescriptions that specify neither the ap-
propriate therapeutic approach nor the therapeutic goal.
So far, there have not been any therapeutic concepts
concentrating solely on enhancing patients’ participa-
tion. Recent developments in treatment, such as arm
ability training, constraint-induced movement therapy
(CIMT), and robot-assisted arm rehabilitation, focus on
the improvement of activities of daily living as prerequi-
sites of participation. These concepts are recommended
by guidelines [6], since they have shown evidence of
good therapeutic results [7] in terms of motor function
improvement and improvements to the dexterity of the
affected arm, as well as a clinically relevant effect on the
usage of the affected arm during activities of daily living.
Whereas these therapies are now increasingly being used
in in-patient rehabilitation, they have not yet been
established in ambulatory care (for example, outpatient
physical and occupational therapy) and are not listed in
the German catalogue of care interventions and modal-
ities (Heilmittelkatalog) [8]. In testing CIMT in an am-
bulatory setting, this project provides a contribution
towards an explicit participation-oriented approach to
treating stroke patients in ambulatory care.
Novel aspects of HOMECIMT
Constraint-induced movement therapy is a therapy
shown to be effective in the treatment of stroke patients
largely independent of the post-stroke time [9-11]. In
addition, lasting therapeutic effects have been demon-
strated after the completion of therapy [12]. However, in
this regard, the literature is inconclusive. A Cochrane re-
view [13] and its update [14] found no evidence of
persisting benefits on the outcome disability, while amore recent review [15], which focused on the effect of
CIMT and modified CIMT on activity and participation,
describes evidence on hand mobility. Both reviews rec-
ommend further randomized trials with larger sample
sizes, relevant measures and a sufficient follow-up.
Therefore, HOMECIMT aims to address these requests
in the conception of the trial.
Constraint-induced movement therapy is suitable for
stroke patients with mild to moderate impairment of
their arm and hand function. Among the core elements
are repetitive, task-oriented and daily-life-oriented exer-
cises, ‘shaping’ (that is, training demands that are in-
creased according to patients’ current performance
limits) and the immobilization of the less affected hand
or arm [10]. Patients are actively involved in treatment
planning and delivery. By formulating participation-
oriented goals, patients take personal responsibility for
their treatment. Thus, the approach includes elements of
participatory care. Constraint-induced movement ther-
apy is recommended by the German Society of Neur-
ology as an effective treatment that is superior to
conventional physical therapy methods [6]. Despite this,
CIMT has not yet been established as a treatment option
in statutory health care.
At the University Hospital Hamburg-Eppendorf,
CIMT has been used successfully for the past 10 years
[16-18]. In a feasibility study, we showed that the modi-
fied concept ‘CIMT at home’, which is delivered at pa-
tients’ own homes, is feasible and achieves similar
results to the ‘classic’ CIMT concept [19]. An innovative
aspect of ‘CIMT at home’ is the active involvement of a
non-professional coach (for example, a family member)
to support the patient in the therapeutic process. Pa-
tients are encouraged to practice their exercises under
the guidance of a non-professional coach for two hours
a day over the course of four weeks. The therapist draws
up the exercise program together with the patient, in-
structs the patient and coach in how the exercises
should be performed, and carries out weekly home visits
to supervise the treatment progress.
Thus, the modified CIMT concept trains the increased
use of the affected arm in daily life and in the unique
home environment, so as to enhance one of the prereq-
uisites for improving participation in everyday activities.
So far, no study has compared the use of CIMT in an
ambulatory setting with conventional physical and occu-
pational therapy. In view of this research gap, this ran-
domized controlled trial was designed to evaluate the
efficacy of a modified approach to constraint-induced
movement therapy (‘CIMT at home’) for chronic stroke
patients, compared with conventional physical and occu-
pational therapy (‘therapy as usual’) in terms of their en-
hancement of activities of daily living as one of the
prerequisites for participation. The target group of this
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tion for physical or occupational therapy.
Methods/design
Objectives
The primary objective of this study is to evaluate the ef-
ficacy of a modified approach of constraint-induced
movement therapy (‘CIMT at home’) for chronic stroke
patients with impaired hand or arm function, compared
with conventional physiotherapy and occupational ther-
apy (‘therapy as usual’) with regard to the prerequisites
of participation in everyday activities: that is, to attain a
sufficient arm and hand function.
Secondary objectives are to explore the effects on the
primary endpoint measures six months post-intervention,Figure 1 Design of the HOMECIMT trial. Flowchart showing enrolment,
with regard to the primary endpoint. ITT, intention-to-treat; LOCF, last-obseas well as the effects the treatment has on stroke-related
quality of life, activities of daily living, amount of arm and
hand use, and function and dexterity of the fingers on the
more affected hand or arm, both at the end of the inter-
vention and six months later. Additionally, we will deter-
mine health service utilization and costs.
Study design
The HOMECIMT study is designed as a two-armed, clus-
ter randomized trial with physical and occupational prac-
tices as clusters (see Figure 1). The central randomization
is stratified by region and takes place at the practice level,
to avoid contamination effects from personal contacts.
Owing to the nature of the intervention, neither the thera-
pists nor the patients can feasibly be blinded. However,allocation, follow-up, and analysis for the HOMECIMT trial participants
rvation carried forward.
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The patients’ recruitment practices are randomized to ei-
ther the intervention group (‘CIMT at home’) or the con-
trol group (‘therapy as usual’) and treat the enrolled
patients according to their allocation. On the patient level,
all primary and secondary parameters will be measured at
baseline (T0), at the end of the four-week intervention
(T1) and six months after completing the treatment (fol-
low-up, T3). In addition, patients will fill in a motor activ-
ity log (MAL) to assess quality of movement, a EuroQoL
EQ-5D form, and a health service utilization questionnaire
three months after the end of intervention (T2).Sample size
The sample size was calculated for the two primary out-
come measures quality of movement, as measured by
the motor activity log (MAL-QOM), and performance
time in the Wolf motor function test (WMFT-PT). For
the first primary endpoint (MAL-QOM), an effect size
of 0.5 was pursued based on the reported minimal clin-
ically important improvement of 0.50 on a scale from 0
to 5 [20]. With a power of 80% and an α-error probabil-
ity of 5%, 2 × 64 patients need to be included if the
randomization occurs at the patient level. With an as-
sumed intra-cluster correlation of 0.05 and 3 included
patients per cluster, a design effect of 1.1 was calculated,
increasing the sample size to 72 patients and 24 prac-
tices per group.
For the second primary endpoint (WMFT-PT) an ef-
fect size of 0.55 was calculated based on the minimal
clinically important improvement of 0.60 on the loga-
rithmic performance-time scale [21]. With identical α
and β design effects, a sample size of 63 patients and 21
practices per group was calculated. Since the first
coprimary endpoint requires a larger sample size, the
sample size was chosen accordingly. We decided to ap-
proach 60 practices for participation in the study,
expecting at least 48 to take part, which allows us to
demonstrate effect sizes of 0.49 and greater for the sec-
ond primary endpoint.Recruitment of practices and patients
All physical and occupational therapy practices treating
stroke patients are eligible to participate in the study.
Because the study center is located in Hamburg, recruit-
ment is performed consecutively in selected areas of
northern Germany that are sufficiently accessible for the
study personnel from Hamburg as well as for local ther-
apy practices. Based on community numbers (geograph-
ical recruitment) we formed an area of eight related
regions, each within 50 km of a city. All therapy prac-
tices with known addresses are invited to an information
meeting nearby. Additionally, written information aboutthe study is offered. The study design allows the inclu-
sion of one therapist per practice.
The referrals to the study follow two steps to allow all
eligible patients access to the study. In a first step, active
practices willing to participate are asked to create a list
of all stroke patients currently being treated (incident
and prevalent cases, regardless of prior treatment and
duration of therapy). To identify all potentially eligible
patients, the inclusion and exclusion criteria are
discussed with the study team for each listed patient. All
patients meeting the inclusion criteria obtain written
study information from their therapists and are asked to
meet study personnel for more information about the
study and to provide informed consent (second step).
We aim to include an average of three patients per prac-
tice. The study center records the recruitment process
for each therapy practice, including the names of the
study team, the date, and the result of the patient visit
(whether the patient enrolls or not). Document and data
completeness are checked by a second member of the
study team, who also ensures that all data forms are
returned to the study center. To maintain participants
in the study, we provide good accessibility (telephone
hotline, email, and fax) to the study personnel, who re-
spond to any questions and emerging issues during the
study period.Randomization
Therapy practices are randomly allocated to either
‘CIMT at home’ or ‘therapy as usual’ in a 1:1 ratio,
stratified by region. Following the recruitment of pa-
tients, a research assistant (from the Department of
Medical Biometry and Epidemiology, University Hos-
pital Hamburg-Eppendorf ), who is not involved in the
project, performs the randomization consecutively for
each region. Therapy practices are informed of their
group allocation in writing by the study center. Patients
will be entered into either the intervention group or the
control group based on the study group allocation of
their treating practice.Inclusion and exclusion criteria
Practice inclusion and exclusion criteria
Practices are eligible if they currently treat three or more
patients who meet the inclusion criteria. Participating
therapists are required either to hold a professional
qualification, relevant to the treatment of stroke patients
(for example, the Bobath course), or have at least two
years’ experience in the treatment of stroke patients. All
participating therapists have to provide written informed
consent that they meet, and will adhere to the study re-
quirements and procedures. Practices are excluded if
they already offer CIMT as a therapy option and if
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in the study.
Patient inclusion and exclusion criteria
Patients are eligible for inclusion in the study if they have
had a stroke leading to upper extremity hemiparesis with
mild to moderate impairment of hand or arm function at
least six months prior to study enrolment (minimal re-
sidual hand function of at least 10° active wrist extension,
at least 10° active thumb abduction or extension, and at
least 10° extension of two additional fingers). Further in-
clusion criteria are: an indication and a prescription for
physical or occupational therapy, age ≥ 18 years, and the
availability of a non-professional coach (for example, a
family member).
Patients meeting the following criteria are excluded:
insufficient ability to communicate in German, severe
impairment of verbal communication ability (for ex-
ample, severe aphasia), inability to consent (for example,
dementia), severe neurocognitive deficits (mini-mental
status test <23), terminal illness, life-threatening comor-
bidities, previous treatment using CIMT, or simultan-
eous participation in another treatment study targeting
stroke recovery.
Data collection
After obtaining written informed consent, therapists
and patients are registered in the study center of the
Department of Primary Medical Care, Hamburg
(Germany), which is responsible for administration,
coordination, data management, and monitoring (in-
cluding database-set up and validation, data entry, cod-
ing, and query management).
Therapists are asked to fill in a questionnaire with in-
formation about their personal details and those of their
practice. During the four-week intervention, therapists
document the treatment of each study patient, including
information about any additional therapies (for example,
speech therapy, occupational therapy, and physiother-
apy) as well as any adverse events, such as illness or
hospitalization, as well as any vacations. To assure suffi-
cient data quality, all participating therapists will be
monitored by telephone using a standardized documen-
tation sheet.
Patient data collection will be performed by blinded
assessors during home visits conducted at baseline (T0),
after the intervention (T1), and at the six-month follow-
up (T3). In addition, an intermediate telephone inter-
view will be conducted at the three-month follow-up
(T2). All assessors receive training before they start
collecting data and refresher courses will be offered dur-
ing the study. The study center provides the assessors
with standardized paper-based interview forms and test
materials. The assessors are blinded to the patients’group affiliation. They have no access to study com-
puters and documents, and are not involved in any
other study aspects, apart from the data collection in
the patients’ homes. To keep assessors blinded, patients
and non-professional coaches are prompted to give no
information to the assessors, neither about their treat-
ment nor about other experiences from participating in
the study.Outcome measures
Primary outcome
We do not know of any generally accepted direct meas-
ure of participation, particularly not for people with im-
paired hand or arm function. Therefore, we use two
subscores, MAL-QOM and WMFT-PT as coprimary
outcomes; these measure activity and motor function of
the impaired hand and arm as important prerequisites
for participation in activities of daily living. Both mea-
surements are customarily used in trials with CIMT and
will be measured four weeks post-treatment relative to
the baseline performance.
In the MAL-QOM, patients assess quality of move-
ment for 30 daily activities on a scale from 0 (= no use
of hand or arm) to 5 (= normal usage), focusing on the
change in quality of arm and hand use. In the WMFT-
PT, the average time in seconds needed to complete 15
tasks is measured by an assessor to evaluate changes in
arm and hand function.Secondary outcomes
The following parameters are secondary outcome mea-
sures taken four weeks post-treatment and at the six-
month follow-up (relative to the baseline performance):
the amount of arm usage, as rated in the MAL), the
functional ability of the hand and arm (measured using
the Wolf motor function test), finger dexterity (the nine
hole peg test) [22], generic quality of life (EuroQoL
form, EQ-5D) [23] and stroke-related quality of life
(measured on the Stroke Impact Scale) [24], independ-
ence in daily life (Barthel Index) [25], and instrumental
activities of daily living [26]. In addition, the following
patient information is collected during the baseline as-
sessment to allow for adjustment of any treatment ef-
fects: sex, age, depression (measured using the PHQ-9)
[27], comorbidity [28], pain [29], neuropsychological
deficits (measured using the mini-mental status test,
MMST) [30], and level of education. Furthermore,
health care utilization and total health care costs will be
calculated.
To study the impact of cluster characteristics on the
main outcomes, the therapists’ ages, sex, and profes-
sional experience, as well as data on the sizes of the
practices (number of patients and treatment units per
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12 months) will be obtained.
Quantitative and qualitative process evaluation will
be conducted at the end of the study: the therapists, pa-
tients, and non-professional coaches of the intervention
groups will be asked about their acceptance of ‘CIMT at
home’ through a questionnaire or structured interview.
Therapists will report on their experiences of ‘CIMT at
home’ in focus groups, with a special focus on supporting
and limiting factors.
Data analysis
Data will be analyzed according to the CONSORT state-
ment extension for cluster randomized trials [31]. A de-
tailed statistical analysis plan will be prepared and
finalized before the code is broken. This is a cluster ran-
domized trial with two treatment arms to confirm the
two-tailed hypothesis: ‘CIMT at home’ (intervention) is
superior to ‘therapy as usual’ (control). The intention-
to-treat (ITT) analysis of primary data will be based on
the available clinical data from all randomized patients
(MAL-QOM) or blinded assessors (WMFT-PT) at T1
(after the end of the four-week intervention), and on the
characteristics of the clusters (practices). In case of
missing follow-up values, a last-observation carried for-
ward (LOCF) imputation will be performed, that is, the
baseline determination will be imputed as follow-up de-
termination. For each of the two primary endpoints, a
linear mixed model will be calculated for the difference
between the intervention and control groups at T1.
Group and region will be considered fixed effects while
practice will be considered a random effect under con-
trol of the baseline covariates (baseline values of the
specific outcome, age, depression (PHQ-9), comorbid-
ity, neuropsychological deficits (result of MMST), edu-
cational level), and sex of patient and therapist. The two
primary endpoints will be tested hierarchically at the
two-sided α-level of 0.05. First, the first primary end-
point (MAL-QOM) will be tested and, if a significant
difference is detected, the second primary endpoint
(WMFT-PT) will be analyzed at the same test level.
Missing values will not be replaced for the primary ana-
lysis. However, sensitivity analyses will be performed
with different methods of missing value imputation to
study the robustness of the findings. An additional ana-
lysis will be conducted on a per-protocol analysis set.
Only the result of this primary efficacy analysis will be
interpreted in a confirmatory manner.
The secondary endpoints will be examined in an ex-
ploratory manner with appropriate procedures, including
subgroup analyses of patients and therapists according to
their sex. Analyses of secondary endpoints should provide
an indication on the consistency of the results from the
evaluation of primary endpoints. The process evaluationwill be carried using qualitative interviews and standard-
ized questionnaires for participants and therapists.
Interim analyses are not planned. Statistical analyses
will be carried out with SAS, Version 9.3 (SAS Institute,
Cary, NC, USA).
Intervention
Patients in the intervention group receive ‘CIMT at
home’, a complex intervention based on a modification
of CIMT for the use in the patient’s individual home
environments.
In the original technique [32], CIMT is administered
by a therapist (physical, occupational) or psychologist
for six hours, every weekday, over the course of two
weeks. Additionally, patients wear a resting hand splint
on their unaffected arm, aiming to prevent use of that
arm for about 90% of waking hours. Overall, about 60
hours of professional training and supervision are pro-
vided. The CIMT core elements are: active, repetitive
training, exercises relevant to everyday life, participative
goal attainment, adaptation to the patient’s options
(shaping), and restriction of the less affected arm.
Based on our long-standing experience with the ori-
ginal CIMT, we developed the modification ‘CIMT at
home’, which is applicable in the patients’ homes with
less professional effort. In a previous feasibility study,
we showed that ‘CIMT at home’ was not only feasible
but also as effective as the original technique [19]. In
contrast with the original technique, ‘CIMT at home’ in-
cludes 40 hours of training over the course of four
weeks and is performed in the patients’ homes, together
with a non-professional coach (for example, a family
member). Once a week, the therapy is supervised by a
physical or occupational therapist. Thus, about five
hours of professional supervision are provided.
Course of the intervention
During an initial home visit, therapists will determine
(together with the patients) an individually tailored home
training program, focusing on everyday practice and will
instruct non-professional coaches. Over the course of
four weeks, that is, 20 consecutive days (no training is re-
quired on weekends), the patients will train for two hours
a day, together with their instructed non-professional
coach (for example, a family member) at home. During
this time, the patients and their coaches will be applying
shaping techniques. Patients are instructed to wear a
resting mitten (see Figure 2) for four to six hours a day
during the entire treatment period, and are encouraged
to keep a training diary to document their daily exercises,
times of training and periods of mitten wearing. A review
of the training diaries will allow quality control by verify-
ing whether the therapy was carried out in accordance
with the ‘CIMT at home’ concept. During the four-week
Figure 2 Therapy concept. This figure illustrates one of the key therapeutic principles of CIMT: restriction of the less affected hand induces the
patient to use the affected arm to drink a glass of water as a typical activity of daily living.
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to instruct the patients and to supervise the training (five
home visits in total, equal to ten treatment units or 250
to 300 minutes). To support the therapists in delivering
this new therapeutic concept, an expert telephone hotline
will be provided.
Training of therapists
Physical and occupational therapists receive training in
the modified therapy approach ‘CIMT at home’, includ-
ing: (1) information on the theoretical background of
CIMT, (2) the principles of CIMT, (3) the therapeutic
concept of ‘CIMT at home’ (cognitive preparing, re-
striction of motion, motor training, shaping techniques
(practice routine, motivation), the schedule of the four-
week intervention (home visits 1 to 5), documentation
(target and therapy agreements, training, activities of
daily living, and wearing the mitten)), and (4) training
in the selection of suitable exercises relevant to every-
day life.
Control
Patients in the control group receive the usual care
(‘therapy as usual’) dose-matched to the intervention
group treatments (10 treatment units or 250 to 300 mi-
nutes). ‘Therapy as usual’ consists of a variety of therapy
options for stroke patients (for example, Bobath, Vojta,
or proprioceptive neuromuscular facilitation) usually
provided by occupational or physical therapists. Ther-
apy sessions take place in the patients’ homes or at the
therapists’ practices. Therapists in the control groupapply ‘therapy as usual’ in accordance with the present
prescription and their individual therapy knowledge and
preferences. Hence, it is possible that patients of the
control group receive different types of therapy (for ex-
ample, Bobath, Vojta, or proprioceptive neuromuscular
facilitation) during their four-week treatment course.
This is a common scenario in therapeutic practice and
will, therefore, be tolerated in the study. In any case, all
patients will receive the same amount of treatment (that
is, 10 treatment units or 250 to 300 minutes).
The therapists will receive written instructions on the
course of therapy for their study patients. During the
four-week intervention phase the therapists will docu-
ment the performed therapy sessions, as well as any
agreements (for example, homework) made with patients
using a standardized documentation sheet. To motivate
the control group therapists to participate in the study,
they will be offered the ‘CIMT at home’ training after
the end of the follow-up phase.
Monitoring of potential unintended harms and adverse
events
During study participation, hospitalizations and severe dis-
eases will be documented as well as any adverse events. Re-
garding the therapy, no specific adverse events are expected,
since the indication for physiotherapy or occupational ther-
apy is mandatory for all study participants. Nevertheless, po-
tential unintended harms may include falls, frailty, and
severe depression. In addition, patients of the intervention
group may perceive some of the CIMT specific conditions
(for example, the daily exercise program or the wearing of a
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tients, non-professional coaches, therapists, and assessors)
will be encouraged to report any events. Feedback and de-
tails of events will be documented and evaluated at the end
of the study.
Quality control and quality assurance
The data management center is at the University Medical
Center Hamburg-Eppendorf. A trial steering committee
composed of the principal investigator, experts in the field
of CIMT and the data management center is responsible
for all decisions concerning the conduct of the study. The
trial’s study team (Department of Primary Medical Care,
University Medical Center Hamburg-Eppendorf) will be re-
sponsible for monitoring the trial. Study employees will
regularly contact the trial sites (therapists and assessors), to
ensure that the rights of the trial participants are protected,
the study data is documented correctly and completely, and
that the trial is conducted in accordance with the study
protocol and complies with good clinical practice and legal
requirements at the trial site. A scientific advisory board
supports the study management in scientific questions
concerning study design, implementation, and evaluation.
Ethics and legal aspects
The study is being conducted in accordance with the
Helsinki Declaration and the ICH Guidelines for Good
Clinical Practice. The study team is committed to
performing all study procedures in accordance with the
standards of good clinical practice. All participating ther-
apists and assessors will be informed of their responsibil-
ities by the study team. The study protocol was
approved by the Ethics Committee of the Medical Asso-
ciation of Hamburg in April of 2011 and was amended
in July of 2011 (Approval-No. PV 3737). It has been reg-
istered under www.clinicaltrials.gov (NCT01343602).
Study timeframe
The study’s duration totals three years, (see Figure 3).
The recruitment of the therapy practices started in JulyFigure 3 Timeline of the HOMECIMT trial.2011 (first region) and was finished in January 2013. The
recruitment of patients started in September 2011 (first
patient in) and ended in March 2013 with the last
patient-out date set for 1 October 2013. The central
randomization is stratified by region as soon as all pa-
tients of the region are included. The training of asses-
sors is also organized regionally. Data collection is
conducted consecutively according to the regional re-
cruitment strategy.Discussion
In the ambulatory care of chronic stroke patients, a
therapy approach with a specific focus on participation
is lacking. Constraint-induced movement therapy pro-
vides an evidence-based, effective, and activity-oriented
treatment for stroke patients. Our previous feasibility
study showed that the modified CIMT program ‘CIMT
at home’ is an effective treatment option for chronic
stroke patients with motoric hand or arm problems in
ambulatory care [19]. The HOMECIMT project is
designed to show whether ‘CIMT at home’ is superior
to ‘therapy as usual’ with regard to its enhancement of
patients’ activities of daily living as prerequisites of par-
ticipation in everyday activities. If ‘CIMT at home’
proves the superior treatment, an explicit participation-
oriented therapy for stroke patients in ambulatory care
would be available. In this case, ‘CIMT at home’ could
be readily implemented in routine care, since its prac-
tical implementation has already been considered in
the development of the program and the concept takes
existing resources into account. If necessary, results
from the focus group sessions with the intervention
group therapists will be used to improve and further
develop the concept. In line with the CONSORT state-
ment, the results of this trial will be presented in the
context of a systematic review of the existing random-
ized controlled trial evidence.Trial status
Recruitment was completed in March 2013.
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